Skip to main content
Algernon Health Inc. logo

Algernon Health Inc. — Investor Relations & Filings

Ticker · AGN CSE Human health and social work activities
Filings indexed 308 across all filing types
Latest filing 2024-01-25 Regulatory Filings
Country CA Canada
Listing CSE AGN

About Algernon Health Inc.

https://www.algernonhealth.com/

Algernon Health Inc. is a healthcare company focused on the provision of advanced diagnostic services, primarily through the establishment of medical clinics specializing in Alzheimer's disease. A key offering is the utilization of brain-optimized Positron Emission Tomography (PET) scanning technology for screening and imaging within a planned network of North American facilities. The company maintains a clinical-stage drug development and repurposing division, which investigates existing, approved drugs for new therapeutic applications targeting unmet global medical needs.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Regulatory Filings
2024-01-25 English
News release - English.pdf
Regulatory Filings
2024-01-24 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2023-12-29 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2023-12-29 English
Annual MD&A - English.pdf
Regulatory Filings
2023-12-29 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2023-12-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.